GlassScriptPhysician profile
Nathaniel Scott Franley
NPI 1992096549
$5,008.38
in general payments reported to CMS, 2019-2025
42 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $471 · 2021: $881 · 2022: $680 · 2023: $1,007 · 2024: $927 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,229.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.09 | 2020-2025 | |
| Pfizer INC. | $670.18 | 2019-2024 | |
| Amgen INC. | $488.83 | 2019-2024 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $412.40 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $357.46 | 2021-2024 | Freestyle Libre 3, Proclaim |
| Astrazeneca Pharmaceuticals LP | $332.96 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $244.83 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $167.23 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $154.76 | 2023-2024 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $124.99 | 2025 | Ultomiris |
| Merck Sharp & Dohme LLC | $102.03 | 2020-2024 | Gardasil 9, Gardasil, M-M-R II |
| Amarin Pharma, INC. | $86.20 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $74.83 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.22 | 2019-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $70.10 | 2019-2024 | Eliquis |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Franley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.